Abstract:Mycotic keratitis is common in warm, humid regions with a varying profile of pathogenic fungi according to geographical origin, socioeconomic status, and climatic condition. Clinical diagnosis can be challenging in difficult cases and those refractory to treatment. Fungal hyphae on microscopic examination and culture isolation have been the gold standard in the laboratory diagnosis of fungal keratitis. A culture isolate of the aetiological fungus is essential to perform antifungal susceptibility testing. As the culture isolation of fungi is time-consuming, causing delays in the initiation of treatment, newer investigative modalities such as in vivo confocal microscopy and molecular diagnostic methods have recently gained popularity. Molecular diagnostic techniques now help to obtain a rapid diagnosis of fungal keratitis. Genomic approaches are based on detecting amplicons of ribosomal RNA genes, with internal transcribed spacers being increasingly adopted. Metagenomic deep sequencing allows for rapid and accurate diagnosis without the need to wait for the fungus to grow. This is also helpful in identifying new emerging strains of fungi causing mycotic keratitis. A custom-tear proteomic approach will probably play an important diagnostic role in future in the management of mycotic keratitis. Positive repeat cultures are being suggested as an important gauge indicative of a poor prognosis. Positive repeat fungal cultures help to modify a treatment regimen by increasing its frequency, providing the addition of another topical and oral antifungal agent along with close follow-up for perforation and identifying need for early therapeutic keratoplasty. The role of collagen crosslinking in the treatment of fungal keratitis is not convincingly established. Rapid detection by multiplex PCR and antifungal susceptibility testing of the pathogenic fungi, adopted into a routine management protocol of fungal keratitis, will help to improve treatment outcome. Early therapy is essential in minimizing damage to the corneal tissue, thereby providing a better outcome. The role of conventional therapy with polyenes, systemic and targeted therapy of antifungal agents, newer azoles and echinocandins in fungal keratitis has been widely studied in recent times. Combination therapy can be more efficacious in comparison to monotherapy. Given the diversity of fungal aetiology, the emergence of new corneal pathogenic fungi with varying drug susceptibilities, increasing the drug resistance to antifungal agents in some genera and species, it is perhaps time to adopt recent molecular methods for precise identification and incorporate antifungal susceptibility testing as a routine.

Challenges in management of microbial keratitis during COVID-19 pandemic related lockdown: a comparative analysis with pre pandemic data

Effects of the COVID-19 Pandemic on Microbial Keratitis: A 5-Year Comparative Study

Presentation of Infectious Keratitis to ED during COVID-19 Lockdown

Impact of SARS-CoV-2 pandemic and lockdown measures on microbial keratitis in Taiwan

Microbial keratitis and its management at a rural centre: achieving success with limited resources

Management of microbial keratitis in general practice

Microbial Spectrum of Keratitis at a Rural Tertiary Care Teaching Hospital

A clinical study of rhino-orbital-cerebral mucormycosis during the COVID-19 pandemic in western Maharashtra

Strategies for successful management of moderate and severe Mooren's ulcer at a rural center during the COVID-19 pandemic: Lessons learnt

Global Ophthalmology Practice Patterns during COVID-19 Pandemic and Lockdown

Clinical perspective and outcome of culture-negative microbial keratitis: A retrospective study

Comparative study on costs incurred for treatment of patients with bacterial and fungal keratitis - A retrospective analysis

Effect of the COVID-19 Pandemic Lockdown on the Management of Diabetic Retinopathy: A Cross-Sectional Study

Recent Perspectives in the Management of Fungal Keratitis

COVID‐19 and its effect on the provision of ophthalmic care in the United Kingdom

Pediatric cataract surgery practices in the COVID-19 era: Perspectives of a tertiary care institute in Northern India

Non-viral Microbial Keratitis in a Tertiary Care Hospital in Bangladesh

Clinicopathological presentations of eyelid malignancy in COVID era versus pre-COVID era

Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation

Epidemiology and clinical outcomes of microbial keratitis in South East Nepal: a mixed-methods study

Impact of Covid-19 on Pediatric Ophthalmology Care: Lessons Learned